This discrepancy is just not shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have related or bigger potencies than copyright as dopamine reuptake inhibitors. These conclusions have evoked a speculation that copyright might also perform as a s